DAY 1
Sunday, 26 May
OPENING CEREMONY
- 17:00-19:00 Welcome addresses
Awards Ceremony
Opening Lecture – Pushing forward the frontier of cfDNA diagnostics – Dennis Lo (Hong Kong, China)
DAY 2
Monday, 27 May
- IFCC SYMPOSIUM 1
09:00-11:00 PRESENT AND FUTURE OF CHRONIC KIDNEY DISEASE AND ACUTE KIDNEY INJURY DETECTION
Chair: Joe M. El-Khoury (USA)
Updates on new eGFR equations and acute kidney injury definitions –
Joe M. El-Khoury (USA)
An update on albuminuria as a chronic kidney disease marker – Joris Delanghe (Belgium)
Everything is acute until it becomes chronic – biomarkers of kidney injury – Rajeevan Selvaratnam (Canada)
Using machine learning methods and leveraging electronic health records for acute kidney injury detection and management – Lama Ghazi (UK) - SYMPOSIUM 1
09:00-11:00 THE PROMISE OF – OMICS BIOMARKERS
Chairs: Hans Jacobs (the Netherlands), Christa M. Cobbaert (the Netherlands)
Glycomics and glycoproteomics: a new biomarker domain debuts in translational research – Manfred Wuhrer (the Netherlands)
Dynamic monitoring of myeloma minimal residual disease with targeted mass spectrometry – Hans Jacobs (the Netherlands)
Integration of artificial intelligence and plasma steroidomics with Laboratory Information Management Systems: application to primary aldosteronism – Graeme Eisenhofer (Germany)
Two oral communications from abstracts - SYMPOSIUM 2
09:00-11:00 APTAMERS BASED DIAGNOSTIC FOR BIOMEDICAL APPLICATIONS
Chair: Mohammed Zourob (Saudi Arabia)
Development of diagnostics for SARS-CoV-2 with high-affinity DNA aptamers – Yingfu Li (Canada)
Continuous, real-time drug measurements in situ in the living body – Kevin Plaxco (USA)
Development of rapid and low-cost aptameric biosensors for biomedical applications – Mohammed Zourob (Saudi Arabia)
Two oral communications from abstracts - AFCB SYMPOSIUM 1
09:00-11:00 METABOLIC DISEASES IN ARABIC COUNTRIES
Chair: Myrna Germanos (Lebanon)
Rare genetic diseases in the MENA region – Andre Megarbane (Lebanon)
Inborn errors of immunity in highly consanguineous populations: from diagnosis to intervention – Mohamed Ridha Barbouche (Bahrain)
Epidemiology of the lysosomal storage disorders (LSDs) IN NORTH Africa – Layachi Chabraoui (Morocco)
Overweight and Obesity: the Weight of Genes – Mohamed Makrelouf (Algeria) - WASPaLM SESSION
09:00-11:00 THE ROLE OF CLINICAL LABORATORY IN THE DEVELOPMENT OF NEW DRUGS
Chair: Roberto Verna (Italy)
The Laboratory in Clinical Research – Roberto Verna (Italy)
The Role of Microbiota in Human Health – Luigina Romani (Italy)
Cultures in Space: Production of New Molecules with Possible Pharmacological Action – Mariano Bizzarri (Italy)
Revolutionizing Antibiotic Strategies: The Power of Innovative Technologies – Veronica Seija (Uruguay) - EFLM SESSION
09:00-11:00 GREEN LABS. IMPLEMENTING SUSTAINABLE PRACTICES IN MEDICAL LABORATORIES
Chair: Tomris Ozben (Turkey)
Green labs: Implementing sustainable practices in medical laboratories – Tomris Ozben (Turkey)
Striking the Right Balance: Sustainability and Innovation – Ffion Jackson (UK)
Strategies for energy conservation and sustainability – Snezana Jovicic (Serbia)
Waste management for clinical laboratories – Alistair Gammie (UK) - 09:00 – 09:15 Opening Message – Sara AlAmeri
UAE GDA SESSION
DIET & LONGEVITY
Moderator: Sean Ng
09:15 – 09:30 Landscape of Longevity Medicine in UAE – Jaffer Khan
09:30 – 09:45 Biomarkers of Aging & Longevity – Alexi Zhavoronkov (USA)
09:45 – 10:00 Nutrigenomics – Sumantra Ray (UK)
10:00 – 10:15 Lipidomic – Vincenzo Di Donna (Italy) - UAE GDA SESSION
MICROBIOME & EPIGENETICS
Moderator: Shaikha Almazrouei
10:15 – 10:30 The world’s most advanced 3D bioprinted human skin models for testing microbiome, vaccines and health – Collin McGukin (France)
10:30 – 10:45 Gut Microbiome Mediated Epigenetic Modifications – M. Azzam Kayasseh
10:45 – 11:00 Epigenetics and Cancer – Ali Hamiche - 11:30 – 12:30 PLENARY LECTURE Precision, Prevention and Women’s Cardiovascular Health: A Global Perspective – Samia Mora (USA)
- 12:30 – 13:00 POSTER SESSION + LUNCH
- 13:00 – 14:00 WORKSHOPS + LUNCH
History & Basic of Genetics | Molecular Genetic Tools & technology – Lova Satyanarayana Matsa - UAE GDA SESSION
ELEVATING LONGEVITY: STEM CELLS, BRAIN HEALTH, AND SMART AGING
Moderator: Jaffe Khan
14:00 – 14:30 Stem Cell Treatment & Longevity – Sean Ng (Malysia)
14:30 – 15:00 Novel strategies to delay brain ageing and cognitive decline – David Vauzour (UK)
15:00 – 15:30 Mitochandrial Transplantation – Giuseppe Orlando
15:30 – 16:00 Cellular smart aging – Helen Margaret Blau
16:00 – 16:45 Panel discussion: Smart aging & longevity – David Vauzour (UK), Sean Ng (Malysia), Helen Margaret Blau, Alex Zhavoronkov (USA), Sumatra Ray (UK) - IFCC SYMPOSIUM 2
14:30 – 16:30 FLOWCYTOMETRY PRINCIPLES AND ITS ROLES IN PRECISION MEDICINE
Chair: Claude Lambert (France)
Principle of flow cytometry and issues in diagnosis – Claude Lambert (France)
FCM in characterizing Lymphoproliferative disorders – Mohamed Brahimi (Algeria)
FCM in diagnosis of immunological disorders and biotherapies – Frederic Vely (France)
FCM in characterizing acute leukemic disorders – Heba Raslan (Saudi Arabia) - SYMPOSIUM 3
14:30-16:30 THOUGHTS ON MAINTAINING INNOVATION AND AVAILABILITY OF MEDICAL TESTS OR HOW TO MEET REGULATORY CHALLENGES FOR LAB-DEVELOPED-TESTS
Chairs: Michael Neumaier (Germany), Christa M. Cobbaert (the Netherlands)
Regulatory considerations for Laboratory-Developed Tests from an international perspective: Opportunities and risks for patient care – Folker Spitzenberger (Germany)
Impact of diagnostic regulations on laboratory developed tests in the US – Tina Lockwood (USA)
Off-label Diagnostics – an analogy to individualized therapeutic medicine: the oncology case – Michael Neumaier, Ralf Hofheinz (Germany)
Two oral communications from abstracts
DAY 3
Tuesday, 28 May
- IFCC SYMPOSIUM 3
09:00-11:00 THE POTENTIAL OF SINGLE CELL AND SPATIAL BIOLOGY IN THE EVOLUTION OF CLINICAL MEDICINE
Chairs: Andrew South, Paolo Fortina (USA)
Using single-cell RNA-sequencing to interrogate biologic drug response in psoriasis – Raymond Cho (USA)
Understanding chronic wounds and wound healing using single cell profiling –Ignacia Fuentes
Deconvolution of Cell Populations in Non-Melanoma Skin Cancer Using single cell RNA-Seq and Nanostring digital spatial profiling – Bonnie LaFleur
Determining the mechanism of action of cancer therapeutics through single cell profiling – Paolo Fortina (USA) - SYMPOSIUM 4
09:00-11:00 THE ROLE OF LABORATORY MEDICINE IN DIRECT-TO-CONSUMER TESTING (DTCT)
Chair: Sverre Sandberg (Norway)
What is Direct To Consumer Testing, DTCT and is it compatible with the “choose wisely” campaign? – Sverre Sandberg (Norway)
The variety and range of direct-to-consumer testing – Patti Shih (Australia)
We must speak up – what is the role of laboratory medicine in DTCT? – Matthias Orth (Germany)
Two oral communications from abstracts - SSCC SYMPOSIUM 1
09:00-11:00 INBORN ERRORS OF METABOLISM IN SAUDI ARABIA
Chair: Ali Alothaim (Saudi Arabia)
Novel inborn errors of metabolism discovery in Saudi Arabia – Majid Alfadhel (Saudi Arabia)
Landscape of Mitochondrial disorders in Saudi Arabia – Naif Almuntashri (Saudi Arabia)
Overview of Newborn screening program in Saudi Arabia – Faud Almutairi (Saudi Arabia)
Integrates genomic and Metabolomics technologies to unravel the diagnostic odyssey in rare diseases – Malak Alghamdi (Saudi Arabia) - SYMPOSIUM 5
09:00-11:00 MACHINE LEARNING AND CLINICAL DECISION SUPPORT: TECHNOLOGIES THAT
GENUINELY MAKE PEOPLE’S LIFE BETTER
Chair: Hernán Fares Taie (Argentina)
Clinical decision support and Machine Learning: Improving medical decisions and enhancing the value of the clinical laboratory in healthcare – Hernán Fares Taie (Argentina)
Navigating Through Current ML Applications in Clinical Labs: From Preanalytical to Post-analytical Phases – Deniz Ilhan Topcu (Turkey)
Machine Learning in healthcare: Current applications and future perspectives – Stephen Master (USA)
Two oral communications from abstracts - UAE SYMPOSIUM 1
09:00-11:00 METABOLIC AND NONCOMMUNICABLE DISEASES
Chair: Fayha Salah Ahmed (UAE)
UAE cardiometabolic guidelines – Hani Sabbour (UAE)
The burden of Non-alcoholic fatty liver disease: screening, diagnosis and management. – Fayha Salah Ahmed (UAE)
Diabetes in UAE – Riad Bayoumi (UAE)
Markers of Alzheimer and neurological disorders. – Laila AbdelWareth (UAE) - APFCB SESSION
09:00-11:00 CLINICAL DECISION SUPPORT
Chair: Kay Weng Choy (Australia)
Clinical decision support in clinical practice: a systematic review – Adriana Esho (Australia)
Electronic clinical decision support for pathology requesting – Ken Sikaris (Australia)
Automated intelligent validation and verification of results – Wei Cui (China)
Considerations for result interpretation clinical decision support – Tze Ping Loh (Singapore) - 09:00 – 09:15 Opening message – Sean Ng
UAE GDA SESSION
STEM CELLS & REGENERATIVE MEDICINE
Moderator: Saba Habibollah
09:15 – 09:30 Embryonic Stem Cells – Majlinda Lako (USA)
09:30 – 09:45 Limbal Stem Cells – Sajjad Ahmad
09:45 – 10:00 Human Embryonic Stem Cells Genetics – Nissim Benvenisty (Israel)
10:00 – 10:15 Umbilical Cord Stem Cells – Marko Strbad - UAE GDA SESSION
CELLULAR TRIUMPHS: ADVANCING CANCER CARE
Moderator: Shaikha Almazrouei
10:20 – 10:40 Cellular Therapy – Sean Ng (Malaysia)
10:40 – 11:00 Bone Marrow Transplant – Shahrukh Hashmi (UAE)
11:00 – 11:20 Cancer Immunotherapy – Carl H. June (USA) - 11:30-12:30 PLENARY LECTURE Genomics in the Middle East: A report card – Fowzan Sami Alkuraya (Saudi Arabia)
- 13:00 – 14:00 WORKSHOPS + LUNCH
Workshop 2: Genetics for Cancer & Pharmacogenomics – Saba Habibollah - UAE GDA SESSION
INNOVATIVE HEALTH SOLUTIONS: 3D MODELS, STEM CELLS, AND PRECISION THERAPIES
Moderator: Marco Strbad
14:00 – 14:30 3D Printed Colorectal Cancer Model for Screening Oncolytic Viruses – Nico Forraz (France)
14:30 – 15:00 Stem Cells & ASD – Salman
15:00 – 15:30 Autoimmune & Vascular Diseases – Dominique Farge (France)
15:30 – 16:00 T Cell Engineering & CART – Michel Sadelain
16:00 – 16:45 Panel Discussion – Stem Cells & Regenerative Medicine – Colin McGukin (France), Majlinda Lako, Sajjad Ahmad, Salman, Michel Sadelain (USA) - IFCC SYMPOSIUM 4
14:30-16:30 ON THE WAY TO CARDIOVASCULAR PRECISION DIAGNOSTICS
Chairs: Christa M. Cobbaert (the Netherlands), Patrick Bossuyt (the Netherlands)
Urgent need for Cardiovascular Precision Diagnostics to address Residual Cardiovascular Risk. – Christa M. Cobbaert (the Netherlands)
Establishing an SI-traceable Reference Measurement System for 7 Serum Apolipoproteins. – Renee Ruhaak (the Netherlands)
Evaluating the Clinical Effectiveness of Cardiovascular Precision Diagnostics. – Patrick Bossuyt (the Netherlands)
Demonstrating the clinical value of a multiplexed serum Apolipoprotein Panel in the Odyssey Outcome
Study. – Esther Reijnders (the Netherlands) - SYMPOSIUM 6
14:30-16:30 DIGITAL COMPETENCE AND ARTIFICIAL INTELLIGENCE IN LABORATORY MEDICINE
Chairs: Damien Gruson (Belgium), Santiago Fares Taie (Argentina)
Embracing the Digital Frontier: Unveiling Unmet Needs in Laboratory Medicine’s AI Journey – Andrea Padoan (Italy)
Revolutionizing Diagnostics: The Clinical Value of Artificial Intelligence in Laboratory Medicine – Damien Gruson (Belgium)
Efficiency Amplified: Unleashing Operational Benefits through Digital Competence and AI in Laboratory Medicine – Osama Elhassan (UAE)
Two oral communications from abstracts
DAY 4
Wednesday, 29 May
- IFCC SYMPOSIUM 5
09:00-11:00 BIOMARKERS FOR NEURODEGENERATIVE DISEASES – IDENTIFICATION, STANDARDIZATION OF PREANALYTICAL AND ANALYTICAL PROCEDURES AND CLINICAL VALIDATION
Chair: Hans Frykman (Canada)
The different clinical types of dementia – epidemiology. – Socratis Papageorgiou (Greece)
Metrological standardization of AD biomarkers – current status future perspectives. – Henrik Zetterberg (Sweden)
Identifying clinically useful biomarkers in neurodegenerative diseases – moving from CSF to blood. – Kaj Blennow (Sweden)
Biomarker panels: analytical and clinical validation against clinically relevant reference standards. – Hans Frykman (Canada) - SYMPOSIUM 7
09:00-11:00 MEETING THE CHALLENGE OF DEMONSTRATING VALUE IN LABORATORY MEDICINE
Chair: Maurice O’Kane
The challenges of delivering value through better test implementation – Maurice O’Kane
The EFLM TE-WG Evaluation Framework and Clinical Needs Assessment Strategy; Key Practical Tools for Value-Based Biomarker Implementation. – Phillip Monaghan (UK)
How we harnessed laboratory data to improve health and economic outcomes – David G. Grenache (USA)
Two oral communications from abstracts - SYMPOSIUM 8
09:00-11:00 HOW TO IMPROVE ACCESS TO LAB TESTING IN MIDDLE & LOW INCOME COUNTRIES?
Chairs: Mario Plebani (Italy), Michael Wilson (USA)
The Lancet Commission on Diagnostics – Michael Wilson (USA)
A Global Diagnostics Alliance – Mikashmi Kohli (Switzerland)
The WHO model list of essential in vitro diagnostics and its role in improving access to lab testing in LMICs – Ana Aceves Capri (Switzerland)
Two oral communications from abstracts - AFCB SYMPOSIUM 2
09:00-11:00 EPIDEMIC AND PANDEMIC INFECTIOUSIS IN ARABIC REGIONS
Chair: Abderrazek Hedhili (Tunisia)
Earthquakes, wars, and emerging infectious disease – Christian Hadad (Lebanon)
Evolution of the epidemiology of viral diseases in relation to migratory movements in the Arab Maghreb countries – Abdelhalim Trabelsi (Tunisia)
Prevalence and incidence Rate of infectious diseases in the Middle east and North Africa: Management of such diseases in low-income countries – Ghassan Shannan (Syria)
Viral transmission from animal to humans (zoonosis) in Middle East Challenges and risks – Robin Abu Ghazaleh (Palestine) - SYMPOSIUM 9
09:00-11:00 HEALTHCARE DELIVERY IN THE 21 CENTURY AND THE ROLE OF THE CLINICAL LABORATORY
Chair: Nader Rifai (USA)
Implementation of Emerging Technologies – Ronda Greaves (Australia)
Sustainability and Environmental Impact of the Clinical Laboratory – Ian Young (UK)
The Role of the Clinical Laboratory in Supporting Equity in the Delivery of Healthcare – Christina Pierre (USA)
Two oral communications from abstracts - COLABIOCLI SESSION
09:00-11:00 EMERGING AND RE-EMERGING DISEASES IN LATIN AMERICA, A VIEW
FROM PUBLIC HEALTH
Chair: Maria Elizabeth Meneses (Brazil)
Current Molecular Diagnosis of Dengue, Zika and Chikungunya in the Region of the Americas – Maria Elizabeth Meneses (Brazil)
Molecular and Epidemiological Aspects of Dengue Infection – Moisés Ramos Solano (Mexico)
Advances in the study of innate immunity against Mycobacterium tuberculosis – Luisa María Nieto Ramirez (Colombia)
Zika a Virus that changed the History of a Generation – Martha Ospina Ramirez (Colombia) - 09:00 – 09:15 Opening Message – Ayman El-Hattab
UAE GDA SESSION
RARE DISEASE
Moderator: Ayman El-Hattab
09:15 – 09:30 Caring for Inborn Error of Metabolism in UAE – Summer Marshall (UAE)
09:30 – 09:50 Genetics of Pediatric Cardiomyopathy: New Findings and Challenges – Alireza Haghighi (USA)
09:50 – 10:05 Genetics of Polycrystic Kidney Disease – Hamad Ali Yaseen (Kuwait)
10:05 – 10:20 Autosomal Recessive Disorders – Musallam Al Araimi
10:20 – 10:35 The Past Decade of Rare Disease in China – Boya Yu (China)
10:35 – 10:50 Neurogenetic Disorders in Children – Arif Khan - 11:30-12:30 PLENARY LECTURE Obesity: novel developments in diagnostics of underlying causes and treatment – Elisabeth van Rossum (the Netherlands)
- 13:00 – 14:00 WORKSHOPS + LUNCH
Workshop 3: Treasure of Life (Introduction & History; Diseases treatable with Stem Cell) – Saba Habibollah - UAE GDA SESSION
WGS FOR INFANTS WITH RARE DISEASES IN UAE
14:00 – 14:30 A Rapid Whole-Genome Sequencing Service for Infants with Rare Diseases in UAE – Ahmad Abou Tayoun - UAE GDA SESSION
POPULATION BASED GENOMICS
14:30 – 15:00 Population Based Genomic approaches to study complex diseases – Youssef Idaghdour (UAE) - UAE SESSION
GENETICS & RARE DISEASES
Moderator: Ahmad Abou Tayoun
15:00 – 15:20 Dystrophin mutation in DMD patients in Thailand, Rare Diseases & Importance of
an early diagnosis – Thanyachai Sura (Thailand)
15:20 – 16:00 Neuromuscular Diseases – Jon Andoni Urtizberea (France), Debra Regier (USA)
16:00 – 16:40 Metabolic Disorders in UAE – Ayman El-Hattab, Lakshmi - AFCC SESSION
14:30-16:30 INBORN ERRORS OF METABOLISM IN AFRICA
Chair: A.B. Okesina (Nigeria)
Challenges in National Newborn Screening Program in Africa – A.B. Okesina (Nigeria)
Prevalence of Inborn Errors of Metabolism in Africa – John I. Anetor (Nigeria)
Clinical, Laboratory and Molecular Spectrum of Galactosaemia in Newborns in Africa – R.T. Erasmus (South Africa)
Requirements for the establishment of Newborn Screening Program in Africa – G.T. Akalu (Ethiopia) - SYMPOSIUM 10
14:30-16:30 TOXICOLOGY ENVIRONMENTAL AND HEALTH EFFECTS
Chair: Abderrazek Hedhili (Tunisia)
Use of Per- and polyfluoroalkyl substances (PFASs) in medical technologies, what are the challenges with finding alternatives, how these technologies containing PFAS are handled at the end of life and how risks are managed – Aldo Tomasi (Italy)
Environmental and health effects of PFOS/PFAS (Mechanisms of action, clinical effects, biological
perturbations, diagnosis, therapy, prevention and measurement) – Kate Hoffman (USA)
Biomedicine and as Biomarker in Clinical Practice and in Environmental Pollution – Alessio Bocedi (Italy)
The evolution of human biomonitoring and its impact on clinical laboratory medicine – David Kinniburgh (Canada) - NAFCC SESSION
14:30-16:30 LABORATORY MEDICINE ADVANCING GLOBAL HEALTH ACROSS THE LIFESPAN
Chair: Octavia M Peck Palmer (USA)
Pediatric health: Vitamin and Trace element testing – Kamisha Johnson-Davis (USA)
New chance at life: Infectious disease testing – Allison A Venner (Canada)
Maternal-fetal health: Early detection of pre-eclampsia – Paul M. Yip (Canada)
Medically underserved populations: Delivering evidence-based care via point of care testing – Octavia M Peck Palmer (USA)
DAY 5
Thursday, 30 May
- SYMPOSIUM 11
09:00-11:00 CIRCULATING CANCER BIOMARKERS: QUO VADIS?
Chair: Ron HN van Schaik (the Netherlands)
Liquid biopsy / cell free DNA analysis: too hot to handle, or right up our alley? – Ron HN van Schaik (the Netherlands)
Liquid biopsy: from discovery to clinical implementation – Klaus Pantel (Germany)
Integrating liquid biopsy with advanced imaging analysis to improve the prediction of response to immune therapy in patients with NSCLC – Marzia del Re (Italy)
Two oral communications from the abstracts - SYMPOSIUM 12
09:00-11:00 PREVENTING KIDNEY DISEASE USING ADVANCED URINE SCREENING AND
KIDNEY DAMAGE MARKERS
Chair: Joris Delanghe (Belgium)
Update to laboratory assessment of kidney diseases – Joris Delanghe (Belgium)
Preventing diabetic nephropathy, follow-up with laboratory markers – Marc De Buyzere (Belgium)
Urine particle analysis in detection of kidney diseases – Rosanna Falbo (Italy)
Two oral communications from abstracts - SSCC SYMPOSIUM 2
09:00-11:00 DYSGLYCEMIA – NOVEL BIOMARKERS FOR DIAGNOSIS AND MONITORING PROGNOSIS
Chair: Suhad Bahijri (Saudi Arabia)
Epidemiology of Diabetes in the Arabian Gulf Countries: Challenges and Opportunities – Yousef Al Saleh (Saudi Arabia)
Use Of Glycated Products In Diagnosis – Nafila Al Riyami (Oman)
Use of 1-hour glucose challenge test in diagnosis and predicting future complications – Jaakko Tuomilehto (Finland)
Novel Biomarkers to improve diagnosis and monitor prognosis – Suhad Bahijri (Saudi Arabia) - SYMPOSIUM 13
09:00-11:00 PERFORMANCE SPECIFICATIONS OF MEDICAL TESTS BASED ON
CLINICAL OUTCOME STUDIES
Chair: Andrea Rita Horvath (Australia)
Outcome-based analytical performance specifications – current status and future directions – Andrea Rita Horvath (Australia)
Testing related outcomes and analytical performance – the linked evidence approach – Patrick Bossuyt (the Netherlands)
A practical approach to determining blood ketone performance specifications – Eric Kilpatrick (Qatar)
Two oral communications from abstracts - SYMPOSIUM 14
09:00-11:00 UTILIZATION MANAGEMENT AND SUCCESSFUL APPROACHES TO CHANGE
AND IMPROVE TEST REQUESTING
Chair: Mario Plebani (Italy)
Utilization management and appropriateness in clinical laboratory: state-of-the-art – Mario Plebani (Italy)
How to deal with inappropriate laboratory retesting? – Ivana Lapic (Croatia)
The noble art of leaving out – Prabath Nanayakkara (the Netherlands)
Two oral communications from abstracts - UAE SYMPOSIUM 2
09:00-11.00 AI & MACHINE LEARNING APPLICATIONS IN LABORATORY MEDICINE
Chair: Laila AbdelWareth (UAE)
Case study of machine learning and AI application in pathology – Ayub Nahal (UAE)
AI and Decision support systems – Hady Elkodary Dubai (UAE)
Intraoperative Mass Spectrometry; Recent updates and Challenges to Implementation – Shereen Hassan Atef (UAE)
Medical Laboratories between shrinking workforce and Artificial Intelligence – Ola Elgaddar (UAE) - 09:00 – 09:15 Opening Message – Mazin Gadir (UAE)
UAE GDA SESSION
GLOBAL HEALTH AI: UNITING NATIONS FOR GENOMIC INSIGHTS AND DATA GOVERNANCE
Moderator: Mazin Gadir (UAE)
09:15 – 09:30 AI and Genomic Insight: Enhancing Public Health though International Partnership – Alireza Haghighi
09:30 – 09:45 Artificial Intelligence and Big Data – Mark Bartlett
09:45 – 10:00 Genomic Data Privacy & Security (Emirati Genom Project) – Tiago R. Magalhaes
10:00 – 10:15 International Collaboration in AI & Healthcare Data Governance – Mazin Gadir (UAE) - UAE GDA SESSION
DIGITAL HEALTH HARMONY: INNOVATIONS IN DATA SHARING AND INTEROPERABILITY
10:15 – 10:30 Digital Health & Innovations – Osama ElHassan (UAE)
10:30-1045 Data sharing & Interoperatibility – Patrick Maloney - UAE GDA SESSION
PANEL DISCUSSION ON CHARTING THE ETHICAL HORIZON: NAVIGATING DATA PRIVACY, SECURITY, AND GOVERNANCE IN HEALTHCARE
Moderator: Osama ElHassan (UAE)
10:45 – 11:30 Charting the Ethical Horizon: Navigating Data Privacy, Security, and Governance in Healthcare – Nouf Al-Numiar, Filippo Castiglione, Alexi Zhavoronkov, Erik Koornneef - 11:30-12:30 PLENARY LECTURE Making molecular diagnostics faster – Carl Wittwer (USA)
- CLOSING CEREMONY
12.30-13.00 Closing Remarks
Welcome to WorldLab 2026
Farewell cocktail